FDA Okays Fingolimod (Gilenya), First Treatment for Pediatric MS FDA Okays Fingolimod (Gilenya), First Treatment for Pediatric MS

The FDA has expanded approval of the oral agent fingolimod from treatment for adults to treatment for children and adolescents aged 10 and up with multiple sclerosis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news